Rhythm Pharmaceuticals, Inc. financial data

Symbol
RYTM on Nasdaq
Industry
Pharmaceutical Preparations
Location
222 Berkeley Street, 12 Th Floor, Boston, MA
State of incorporation
DE
Fiscal year end
December 31
Former names
RHYTHM METABOLIC, INC. (to 8/12/2015)
Latest financial report
10-Q - Q3 2024 - Nov 6, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 475 % -32.8%
Quick Ratio 16.4 % +34%
Debt-to-equity 274 % +348%
Return On Equity -367 % -328%
Return On Assets -77.5 % -45.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 61.5M shares +4%
Common Stock, Shares, Outstanding 61.4M shares +3.97%
Entity Public Float 887M USD +371%
Common Stock, Value, Issued 61K USD +3.39%
Weighted Average Number of Shares Outstanding, Basic 61.2M shares +5.78%
Weighted Average Number of Shares Outstanding, Diluted 61.2M shares +5.78%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 33.3M USD +47.8%
Research and Development Expense 227M USD +76.3%
Costs and Expenses 378M USD +52.9%
Operating Income (Loss) -266M USD -43.4%
Nonoperating Income (Expense) 7.24M USD +34390%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -258M USD -0.43%
Income Tax Expense (Benefit) -344K USD -193%
Net Income (Loss) Attributable to Parent -259M USD -39.5%
Earnings Per Share, Basic -4.33 USD/shares -33.6%
Earnings Per Share, Diluted -0.73 USD/shares +3.95%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 47.5M USD -26.4%
Cash, Cash Equivalents, and Short-term Investments 298M USD -0.29%
Accounts Receivable, after Allowance for Credit Loss, Current 19.3M USD +32.8%
Inventory, Net 13.9M USD +79%
Other Assets, Current 6.67M USD -10%
Assets, Current 340M USD +3.38%
Other Long-term Investments 12M USD -20%
Property, Plant and Equipment, Net 801K USD -48.2%
Operating Lease, Right-of-Use Asset 3.59M USD +304%
Other Assets, Noncurrent 15M USD -9.94%
Assets 364M USD +2.65%
Accounts Payable, Current 4.89M USD +27.3%
Accrued Liabilities, Current 54.8M USD +23.8%
Liabilities, Current 97.6M USD +94.6%
Operating Lease, Liability, Noncurrent 4.03M USD +482%
Other Liabilities, Noncurrent 35.6M USD
Liabilities 211M USD +34.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax -604K USD -435%
Retained Earnings (Accumulated Deficit) -1.11B USD -30.3%
Stockholders' Equity Attributable to Parent 11.2M USD -94.3%
Liabilities and Equity 364M USD +2.65%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -40.7M USD -11.8%
Net Cash Provided by (Used in) Financing Activities 4.24M USD
Net Cash Provided by (Used in) Investing Activities 30.1M USD +62.7%
Common Stock, Shares Authorized 120M shares 0%
Common Stock, Shares, Issued 61.4M shares +3.97%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -6.52M USD +63.8%
Deferred Tax Assets, Valuation Allowance 267M USD +23%
Deferred Tax Assets, Gross 267M USD +22.9%
Operating Lease, Liability 4.03M USD +180%
Payments to Acquire Property, Plant, and Equipment 47K USD -63%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -262M USD -41.4%
Lessee, Operating Lease, Liability, to be Paid 5.91M USD +278%
Property, Plant and Equipment, Gross 5.4M USD +0.9%
Operating Lease, Liability, Current 816K USD +12.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.1M USD +120%
Lessee, Operating Lease, Liability, to be Paid, Year One 456K USD -46.4%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.88M USD +1415%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.13M USD
Deferred Tax Assets, Operating Loss Carryforwards 154M USD +13.4%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.15M USD
Additional Paid in Capital 1.12B USD +6.96%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 858K USD +64.6%
Deferred Tax Assets, Net of Valuation Allowance 338K USD -6.37%
Interest Expense 15.6M USD +55.3%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%